Zhejiang Chimin Pharm Co Ltd
Chimin Health Management Co., Ltd., together with its subsidiaries, researches, develops, produces, and sells vitro diagnostic products and provides medical services in China and internationally. The company provides non-PVC double-tube double-valve, single-tube single-valve, and single-tube double-valve soft bags; plastic bottles; and other packaging forms. It also offers medical instruments, in… Read more
Zhejiang Chimin Pharm Co Ltd (603222) - Cash Flow Conversion Efficiency
Latest cash flow conversion efficiency as of September 2025: 0.003x
Based on the latest financial reports, Zhejiang Chimin Pharm Co Ltd (603222) has a cash flow conversion efficiency ratio of 0.003x as of September 2025.
Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (CN¥3.84 Million) by net assets (CN¥1.49 Billion). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
Zhejiang Chimin Pharm Co Ltd - Cash Flow Conversion Efficiency Trend (2011–2024)
This chart illustrates how Zhejiang Chimin Pharm Co Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data. Explore and compare other companies by cash flow conversion efficiency.
Zhejiang Chimin Pharm Co Ltd Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Zhejiang Chimin Pharm Co Ltd ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Zhejiang Tengen Electrics Co Ltd
SHG:605066
|
N/A |
|
Douglas AG
XETRA:DOU
|
0.436x |
|
Polynovo Ltd
AU:PNV
|
0.190x |
|
Shanghai Yongli Belting Co Ltd
SHE:300230
|
0.037x |
|
Agora Inc
NASDAQ:API
|
0.017x |
|
Marcus Corporation
NYSE:MCS
|
0.086x |
|
SK Networks Co Ltd
KO:001740
|
0.035x |
|
OPUS GLOBAL Nyrt
BUD:OPUS
|
0.077x |
Annual Cash Flow Conversion Efficiency for Zhejiang Chimin Pharm Co Ltd (2011–2024)
The table below shows the annual cash flow conversion efficiency of Zhejiang Chimin Pharm Co Ltd from 2011 to 2024.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2024-12-31 | CN¥1.57 Billion | CN¥72.99 Million | 0.047x | -44.90% |
| 2023-12-31 | CN¥1.66 Billion | CN¥140.20 Million | 0.084x | -26.76% |
| 2022-12-31 | CN¥1.77 Billion | CN¥204.65 Million | 0.115x | -45.24% |
| 2021-12-31 | CN¥1.37 Billion | CN¥289.49 Million | 0.211x | +32.51% |
| 2020-12-31 | CN¥1.05 Billion | CN¥166.29 Million | 0.159x | +11.61% |
| 2019-12-31 | CN¥1.07 Billion | CN¥152.77 Million | 0.142x | +20.21% |
| 2018-12-31 | CN¥1.05 Billion | CN¥123.99 Million | 0.118x | +65.39% |
| 2017-12-31 | CN¥928.28 Million | CN¥66.49 Million | 0.072x | -19.65% |
| 2016-12-31 | CN¥808.94 Million | CN¥72.12 Million | 0.089x | -23.45% |
| 2015-12-31 | CN¥750.99 Million | CN¥87.46 Million | 0.116x | -33.52% |
| 2014-12-31 | CN¥441.55 Million | CN¥77.36 Million | 0.175x | -20.95% |
| 2013-12-31 | CN¥488.13 Million | CN¥108.19 Million | 0.222x | -43.57% |
| 2012-12-31 | CN¥432.53 Million | CN¥169.88 Million | 0.393x | +357.29% |
| 2011-12-31 | CN¥383.04 Million | CN¥32.90 Million | 0.086x | -- |